Conjugate heptavalent pneumococcal vaccine outcome improvements.
Heptavalent conjugate pneumococcal vaccine (PCV7) is now routinely administered to infants. Medical records from a pediatric outpatient clinic were used to identify two study groups: 1) those born between January 1995-May 1997(controls), 2) those born between April 2000--May 2001 (PCV7 group). The PCV7 group showed a lower incidence of otitis media episodes, clinic visits for fever and respiratory symptoms, antibiotic prescriptions, ceftriaxone use, and hospitalizations (singled sided probabilities).